Geneos Wealth Management Inc. Agenus Inc Transaction History

Geneos Wealth Management Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Sep 07, 2021	SELL	$2.51 - $3.73 $2,130 - $3,166	-849 Closed	0 $0
Q2 2018 Sep 07, 2021	SELL	$2.26 - $4.65 $6,779 - $13,950	-3,000 Reduced 77.94%	849 $1,000
Q1 2018 Sep 07, 2021	SELL	$3.51 - $6.04 $3,510 - $6,040	-1,000 Reduced 20.62%	3,849 $18,000
Q4 2017 Sep 07, 2021	BUY	$3.26 - $4.78 $15,807 - $23,178	4,849 New	4,849 $15,000
Q4 2016 Sep 07, 2021	SELL	N/A	-183 Closed	0 $0
Q3 2016 Sep 07, 2021	BUY	N/A	183	183 $1,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.